pubmed-article:18575849 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18575849 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:18575849 | lifeskim:mentions | umls-concept:C0018546 | lld:lifeskim |
pubmed-article:18575849 | lifeskim:mentions | umls-concept:C0073393 | lld:lifeskim |
pubmed-article:18575849 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:18575849 | lifeskim:mentions | umls-concept:C0849912 | lld:lifeskim |
pubmed-article:18575849 | lifeskim:mentions | umls-concept:C2003874 | lld:lifeskim |
pubmed-article:18575849 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:18575849 | pubmed:dateCreated | 2008-9-4 | lld:pubmed |
pubmed-article:18575849 | pubmed:abstractText | Studies on emotional processing report that schizophrenic patients present a specific pattern of emotional responding that usually includes deficits in emotional expressiveness, increased feelings of unpleasant emotion but decreased feelings of pleasant emotion, and increased physiological reactivity. However, studies have rarely controlled the nature of antipsychotic medication. Yet, the influence of these drugs on emotional response is uncertain and could vary depending on their pharmacological profile. | lld:pubmed |
pubmed-article:18575849 | pubmed:language | eng | lld:pubmed |
pubmed-article:18575849 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18575849 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18575849 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18575849 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18575849 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18575849 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18575849 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18575849 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18575849 | pubmed:month | Oct | lld:pubmed |
pubmed-article:18575849 | pubmed:issn | 0033-3158 | lld:pubmed |
pubmed-article:18575849 | pubmed:author | pubmed-author:DelaveauPP | lld:pubmed |
pubmed-article:18575849 | pubmed:author | pubmed-author:AzorinJ MJM | lld:pubmed |
pubmed-article:18575849 | pubmed:author | pubmed-author:BlinOO | lld:pubmed |
pubmed-article:18575849 | pubmed:author | pubmed-author:KhalfaSS | lld:pubmed |
pubmed-article:18575849 | pubmed:author | pubmed-author:FakraEE | lld:pubmed |
pubmed-article:18575849 | pubmed:author | pubmed-author:Da FonsecaDD | lld:pubmed |
pubmed-article:18575849 | pubmed:author | pubmed-author:BesnierNN | lld:pubmed |
pubmed-article:18575849 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18575849 | pubmed:volume | 200 | lld:pubmed |
pubmed-article:18575849 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18575849 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18575849 | pubmed:pagination | 261-72 | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:meshHeading | pubmed-meshheading:18575849... | lld:pubmed |
pubmed-article:18575849 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18575849 | pubmed:articleTitle | Effect of risperidone versus haloperidol on emotional responding in schizophrenic patients. | lld:pubmed |
pubmed-article:18575849 | pubmed:affiliation | CIC-UPCET et Pharmacologie Clinique, Hôpital de la Timone, UMR CNRS 6193 Institut des Neurosciences Cognitives de la Méditerranée, Marseille, France. eric.fakra@ap-hm.fr | lld:pubmed |
pubmed-article:18575849 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18575849 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:18575849 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:18575849 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |